IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools
 

Search About Journals, Conferences, and Book Series


Expert Opinion on Emerging Drugs- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

3.34

h-Index

 51

Rank

 4270

SJR

 0.972

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Expert Opinion on Emerging Drugs
Abbreviation Expert Opin. Emerg. Drugs
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (Q1); Pharmacology (medical) (Q1)
h-index 51
Overall Rank/Ranking 4270
SCImago Journal Rank (SJR) 0.972
Impact Score 3.34
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 14728214, 17447623




About Expert Opinion on Emerging Drugs


Expert Opinion on Emerging Drugs is a journal covering the technologies/fields/categories related to Pharmacology (Q1); Pharmacology (medical) (Q1). It is published by Taylor and Francis Ltd.. The overall rank of Expert Opinion on Emerging Drugs is 4270. According to SCImago Journal Rank (SJR), this journal is ranked 0.972. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 51. The best quartile for this journal is Q1.

The ISSN of Expert Opinion on Emerging Drugs journal is 14728214, 17447623. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Emerging Drugs is cited by a total of 350 articles during the last 3 years (Preceding 2021).




Expert Opinion on Emerging Drugs Impact Score 2021-2022


The impact score (IS) 2021 of Expert Opinion on Emerging Drugs is 3.34, which is computed in 2022 as per its definition. Expert Opinion on Emerging Drugs IS is decreased by a factor of 0.24 and approximate percentage change is -6.7% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Expert Opinion on Emerging Drugs Impact Score 2022 Prediction


IS 2021 of Expert Opinion on Emerging Drugs is 3.34. If the same downward trend persists, impact score may fall in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Expert Opinion on Emerging Drugs. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 3.34
2020 3.58
2019 2.86
2018 2.94
2017 3.34
2016 3.14
2015 2.56
2014 3.13

Expert Opinion on Emerging Drugs h-index


  Table Setting

Expert Opinion on Emerging Drugs has an h-index of 51. It means 51 articles of this journal have more than 51 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Expert Opinion on Emerging Drugs ISSN


The ISSN of Expert Opinion on Emerging Drugs is 14728214, 17447623. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Expert Opinion on Emerging Drugs Rank and SCImago Journal Rank (SJR)


The overall rank of Expert Opinion on Emerging Drugs is 4270. According to SCImago Journal Rank (SJR), this journal is ranked 0.972. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Expert Opinion on Emerging Drugs Publisher


Table Setting

Expert Opinion on Emerging Drugs is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2000-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Expert Opinion on Emerging Drugs is Expert Opin. Emerg. Drugs. This abbreviation ('Expert Opin. Emerg. Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Expert Opinion on Emerging Drugs


If your research field is/are related to Pharmacology (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Revista Internacional de Contaminacion Ambiental journal 20185 Centro de Ciencias de la Atmosfera, UNAM 21 0.46
Energy for Sustainable Development journal 2247 Elsevier 69 5.76
Mathematical Engineering book series 25339 Springer Science + Business Media 8 0.26
Symmetry, Integrability and Geometry: Methods and Applications (SIGMA) journal 11446 Department of Applied Research, Institute of Mathematics of National Academy of Science of Ukraine 36 0.74
Health Promotion Practice journal 10028 SAGE Publications Inc. 54 1.72
Magyar Pszichologiai Szemle journal 23615 Akademiai Kiado 8 0.10
Earthquake Engineering and Engineering Vibration journal 6337 Science Press 48 2.78
Agricultural Economics (United Kingdom) journal 2489 Wiley-Blackwell Publishing Ltd 90 3.54
Permafrost and Periglacial Processes journal 2667 John Wiley and Sons Ltd 80 4.43
Education and Training journal 8048 Emerald Group Publishing Ltd. 71 3.32

Check complete list



Jasper


Year wise Impact Score (IS) of Expert Opinion on Emerging Drugs

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 3.34
2020 3.58
2019 2.86
2018 2.94
2017 3.34
2016 3.14
2015 2.56
2014 3.13



Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All